Codexis Reports Second Quarter 2023 Financial Results
August 03, 2023 16:05 ET
|
Codexis, Inc.
Company Recently Announced Enhanced Strategic Focus and Portfolio Prioritization Anticipate Demonstrating Gram-Scale Synthesis of ECO Synthesis™ Technology for RNAi Therapeutics...
Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics
July 31, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the launch of a new mini documentary as part of an ongoing...
Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
July 20, 2023 16:05 ET
|
Codexis, Inc.
Organization Streamlined to Focus on Continued Advancement and Commercialization of ECO Synthesis™ Platform for RNAi Therapeutics Production Codexis Expects its Pharmaceutical Manufacturing Business...
Codexis Announces New Employment Inducement Grants
June 09, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to four new employees as...
Codexis to Participate in Jefferies Healthcare Conference
May 24, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Healthcare...
Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
May 10, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the unveiling of its Enzyme-Catalyzed Oligonucleotide (ECO)...
Codexis Announces New Employment Inducement Grants
May 08, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to five new employees as...
Codexis Reports First Quarter 2023 Financial Results
May 04, 2023 16:05 ET
|
Codexis, Inc.
CDX-7108 Clinical Development Program Remains on Track Estimated Cash Runway Through End of 2024 Funds Important Upcoming Milestones Company Reiterates 2023 Total Revenue Guidance with...
Codexis to Report First Quarter 2023 Financial Results on May 4
April 20, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first...
Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA
April 19, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a pre-conference workshop highlighting the...